Finkelstein Thompson LLP Announces Investigation of QuadraMed Corp.
11 Dezembro 2009 - 5:09PM
Business Wire
Finkelstein Thompson LLP is investigating potential claims on
behalf of shareholders of QuadraMed Corp. (“QuadraMed” or the
“Company”) (NasdaqGM:QDHC) arising from the Company’s announcement
of its intent to be acquired by Francisco Partners in a going
private transaction.
On December 8, 2009, QuadraMed announced its plan to be acquired
by the private equity firm Francisco Partners. Under the terms of
the merger agreement, QuadraMed shareholders will receive $8.50 in
cash for every share of QuadraMed common stock they own. Just two
days after the announcement of the merger, QuadraMed reported that
the Department of Veterans Affairs renewed a contract with the
Company worth a reported $24 million.
The investigation is focused on the potential unfairness of the
consideration to be paid to QuadraMed shareholders as well as the
potential unfairness of the process by which the QuadraMed Board of
Directors is addressing the transaction.
If you are interested in discussing your rights as a QuadraMed
shareholder, or have information relating to this investigation,
please contact Finkelstein Thompson's Washington, DC offices at
(877) 337-1050 or by email at contact@finkelsteinthompson.com.
Finkelstein Thompson LLP has spent over three decades delivering
outstanding representation to institutional and individual clients
in financial litigation, and has been appointed as lead or co-lead
counsel in dozens of shareholder class actions. Indeed, the firm
has served in leadership roles in cases that have recovered over $1
billion for investors and consumers. To learn more about
Finkelstein Thompson LLP, please visit our web site at
www.finkelsteinthompson.com. Attorney advertising. Prior results do
not guarantee similar outcomes.
Quadramed Corp (MM) (NASDAQ:QDHC)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Quadramed Corp (MM) (NASDAQ:QDHC)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Quadramed Corp (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Finkelstein Thompson LLP